Matches in SemOpenAlex for { <https://semopenalex.org/work/W4225966467> ?p ?o ?g. }
- W4225966467 abstract "Hypothalamic obesity (HO) in children has severe health consequences. Lifestyle interventions are mostly insufficient and currently no drug treatment is approved for children with HO. Amphetamines are known for their stimulant side-effect on resting energy expenditure (REE) and suppressing of appetite. Earlier case series have shown positive effects of amphetamines on weight in children with acquired HO. We present our experiences with dextroamphetamine treatment in the, up to now, largest cohort of children with HO.A retrospective cohort evaluation was performed of children with HO treated with dextroamphetamine at two academic endocrine pediatric clinics. Off-label use of dextroamphetamine was initiated in patients with progressive, therapy-resistant acquired or congenital HO. Anthropometrics, REE, self-reported (hyperphagic) behavior and energy level, and side effects were assessed at start and during treatment.Nineteen patients with a mean age of 12.3 ± 4.0 years had been treated with dextroamphetamine. In two patients, ΔBMI SDS could not be evaluated due to short treatment duration or the simultaneous start of extensive lifestyle treatment. Mean treatment duration of the 17 evaluated patients was 23.7 ± 12.7 months. Fourteen patients (n = 10 with acquired HO, n = 4 with congenital HO) responded by BMI decline or BMI stabilization (mean ΔBMI SDS of -0.6 ± 0.8, after a mean period of 22.4 ± 10.5 months). In three patients, BMI SDS increased (mean ΔBMI SDS of +0.5 ± 0.1, after a mean period of 29.7 ± 22.6 months). In 11 responders, measured REE divided by predicted REE increased with +8.9%. Thirteen patients (68.4%) reported decreased hyperphagia, improvement of energy level and/or behavior during treatment. Two patients developed hypertension during treatment, which resulted in dosage adjustment or discontinuation of treatment. Twelve children continued treatment at last moment of follow-up.In addition to supportive lifestyle interventions, dextroamphetamine treatment may improve BMI in children with HO. Furthermore, dextroamphetamines have the potential to decrease hyperphagia and improve resting energy expenditure, behavior, and energy level. In patients with acquired HO, these effects seem to be more pronounced when compared to patients with congenital HO. Future studies are needed to support these results." @default.
- W4225966467 created "2022-05-05" @default.
- W4225966467 creator A5015949770 @default.
- W4225966467 creator A5029691739 @default.
- W4225966467 creator A5047173492 @default.
- W4225966467 creator A5047249695 @default.
- W4225966467 creator A5050837989 @default.
- W4225966467 creator A5051030716 @default.
- W4225966467 creator A5053216349 @default.
- W4225966467 creator A5055192109 @default.
- W4225966467 creator A5065908068 @default.
- W4225966467 creator A5074923993 @default.
- W4225966467 creator A5075070173 @default.
- W4225966467 creator A5087788976 @default.
- W4225966467 date "2022-03-09" @default.
- W4225966467 modified "2023-10-16" @default.
- W4225966467 title "Dextroamphetamine Treatment in Children With Hypothalamic Obesity" @default.
- W4225966467 cites W1028481409 @default.
- W4225966467 cites W1511786579 @default.
- W4225966467 cites W1639930240 @default.
- W4225966467 cites W1829445008 @default.
- W4225966467 cites W1965959073 @default.
- W4225966467 cites W1976921443 @default.
- W4225966467 cites W1993305928 @default.
- W4225966467 cites W1994391757 @default.
- W4225966467 cites W1998361862 @default.
- W4225966467 cites W2010142606 @default.
- W4225966467 cites W2018085697 @default.
- W4225966467 cites W2028637607 @default.
- W4225966467 cites W2030920339 @default.
- W4225966467 cites W2033892184 @default.
- W4225966467 cites W2040375567 @default.
- W4225966467 cites W2055523122 @default.
- W4225966467 cites W2058239117 @default.
- W4225966467 cites W2064936475 @default.
- W4225966467 cites W2069654038 @default.
- W4225966467 cites W2071560142 @default.
- W4225966467 cites W2078320570 @default.
- W4225966467 cites W2087288531 @default.
- W4225966467 cites W2094166761 @default.
- W4225966467 cites W2112809623 @default.
- W4225966467 cites W2131018443 @default.
- W4225966467 cites W2131686435 @default.
- W4225966467 cites W2237976954 @default.
- W4225966467 cites W2252345599 @default.
- W4225966467 cites W2311863019 @default.
- W4225966467 cites W2623177225 @default.
- W4225966467 cites W2747721206 @default.
- W4225966467 cites W2773477928 @default.
- W4225966467 cites W2886277721 @default.
- W4225966467 cites W2886298463 @default.
- W4225966467 cites W2890877431 @default.
- W4225966467 cites W2894544668 @default.
- W4225966467 cites W2920800083 @default.
- W4225966467 cites W2985819708 @default.
- W4225966467 cites W3048421361 @default.
- W4225966467 cites W3126335602 @default.
- W4225966467 cites W3186323529 @default.
- W4225966467 doi "https://doi.org/10.3389/fendo.2022.845937" @default.
- W4225966467 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35355559" @default.
- W4225966467 hasPublicationYear "2022" @default.
- W4225966467 type Work @default.
- W4225966467 citedByCount "7" @default.
- W4225966467 countsByYear W42259664672022 @default.
- W4225966467 countsByYear W42259664672023 @default.
- W4225966467 crossrefType "journal-article" @default.
- W4225966467 hasAuthorship W4225966467A5015949770 @default.
- W4225966467 hasAuthorship W4225966467A5029691739 @default.
- W4225966467 hasAuthorship W4225966467A5047173492 @default.
- W4225966467 hasAuthorship W4225966467A5047249695 @default.
- W4225966467 hasAuthorship W4225966467A5050837989 @default.
- W4225966467 hasAuthorship W4225966467A5051030716 @default.
- W4225966467 hasAuthorship W4225966467A5053216349 @default.
- W4225966467 hasAuthorship W4225966467A5055192109 @default.
- W4225966467 hasAuthorship W4225966467A5065908068 @default.
- W4225966467 hasAuthorship W4225966467A5074923993 @default.
- W4225966467 hasAuthorship W4225966467A5075070173 @default.
- W4225966467 hasAuthorship W4225966467A5087788976 @default.
- W4225966467 hasBestOaLocation W42259664671 @default.
- W4225966467 hasConcept C126322002 @default.
- W4225966467 hasConcept C167135981 @default.
- W4225966467 hasConcept C187212893 @default.
- W4225966467 hasConcept C2776145449 @default.
- W4225966467 hasConcept C2777193897 @default.
- W4225966467 hasConcept C2780221984 @default.
- W4225966467 hasConcept C511355011 @default.
- W4225966467 hasConcept C513476851 @default.
- W4225966467 hasConcept C71924100 @default.
- W4225966467 hasConcept C72563966 @default.
- W4225966467 hasConceptScore W4225966467C126322002 @default.
- W4225966467 hasConceptScore W4225966467C167135981 @default.
- W4225966467 hasConceptScore W4225966467C187212893 @default.
- W4225966467 hasConceptScore W4225966467C2776145449 @default.
- W4225966467 hasConceptScore W4225966467C2777193897 @default.
- W4225966467 hasConceptScore W4225966467C2780221984 @default.
- W4225966467 hasConceptScore W4225966467C511355011 @default.
- W4225966467 hasConceptScore W4225966467C513476851 @default.
- W4225966467 hasConceptScore W4225966467C71924100 @default.
- W4225966467 hasConceptScore W4225966467C72563966 @default.
- W4225966467 hasLocation W42259664671 @default.